Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IBeTA: Bevacizumab and Triamcinolone with Laser for Diabetic Macular Edema
NCT00997191Phase 3Completed
- Sponsor
- Universidade de São Paulo
- Start
- Oct 2009
- Primary completion
- Nov 2011
- Modality
- Monoclonal Antibodies, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of bevacizumab, triamcinolone in diabetic macular edema (DME), sponsored by Universidade de São Paulo. Started Oct 2009; status: completed.
02
Drugs
bevacizumabtriamcinolone
03
Conditions
diabetic macular edema (DME)
Beyond the preview
Go deeper on NCT00997191.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00997191.